特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
865010

セファロスポリンの世界市場:産業分析、市場シェア・規模・成長率・機会・将来予測

Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 103 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
セファロスポリンの世界市場:産業分析、市場シェア・規模・成長率・機会・将来予測
出版日: 2019年06月10日
発行: IMARC Services Private Limited
ページ情報: 英文 103 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のセファロスポリンの市場について分析し、市場の全体的構造や、市場規模の推移・見通し (過去・今後6年間分)、世代別・投与経路別・用途別および地域別の詳細動向、バリューチェーンの構造と動向、主な市場促進・抑制要因、市場競争環境、主要企業のプロファイルなどについて調査しております。

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブ・サマリー

第4章 イントロダクション

  • 概要
  • 業界の主な動向

第5章 世界のセファロスポリン市場

  • 市場概要
  • 市場規模の実績値
  • 市場区分:世代別
  • 市場区分:投与経路 (RoA) 別
  • 市場区分:用途別
  • 市場区分:地域別
  • 市場規模の予測値

第6章 世代別の市場区分

  • 第一世代
    • 市場動向
    • 市場予測
  • 第二世代
  • 第三世代
  • 第四世代
  • 第五世代

第7章 投与経路別の市場区分

  • 注射
  • 経口投与

第8章 用途別の市場区分

  • 気道感染症
  • 皮膚感染症
  • 耳感染症
  • 尿路感染症
  • 性感染症
  • その他

第9章 地域別の市場区分

  • アジア太平洋地域市場
  • 欧州市場
  • 北米市場
  • 中東・アフリカ市場
  • ラテンアメリカ市場

第10章 SWOT分析

  • 概要
  • 強み・弱み・機会・脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 企業間競争の激しさ
  • 新規参入企業の脅威
  • 代替製品の脅威

第13章 価格分析

  • 価格指数
  • 価格構造
  • 粗利益率の分析

第14章 競争環境

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan Plc.
    • Bristol-Myers Squibb Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline plc
    • Lupin Limited (Lupin Pharmaceuticals, Inc.)
    • Merck & Co. Inc.
    • Novartis International AG (Sandoz)
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Abbott
    • Ranbaxy
    • Merck
図表

List of Figures

  • Figure 1: Global: Cephalosporin Market: Major Drivers and Challenges
  • Figure 2: Global: Cephalosporin Market: Sales Value (in Billion US$), 2013-2018
  • Figure 3: Global: Cephalosporin Market: Breakup by Generation (in %), 2018
  • Figure 4: Global: Cephalosporin Market: Breakup by Route of Administration (in %), 2018
  • Figure 5: Global: Cephalosporin Market: Breakup by Application (in %), 2018
  • Figure 6: Global: Cephalosporin Market: Breakup by Region (in %), 2018
  • Figure 7: Global: Cephalosporin Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 8: Global: Cephalosporin (First Generation) Market: Sales Value (in Million US$), 2013-2018
  • Figure 9: Global: Cephalosporin (First Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 10: Global: Cephalosporin (Second Generation) Market: Sales Value (in Million US$), 2013-2018
  • Figure 11: Global: Cephalosporin (Second Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 12: Global: Cephalosporin (Third Generation) Market: Sales Value (in Million US$), 2013-2018
  • Figure 13: Global: Cephalosporin (Third Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 14: Global: Cephalosporin (Fourth Generation) Market: Sales Value (in Million US$), 2013-2018
  • Figure 15: Global: Cephalosporin (Fourth Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 16: Global: Cephalosporin (Fifth Generation) Market: Sales Value (in Million US$), 2013-2018
  • Figure 17: Global: Cephalosporin (Fifth Generation) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 18: Global: Cephalosporin (Injection) Market: Sales Value (in Million US$), 2013-2018
  • Figure 19: Global: Cephalosporin (Injection) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 20: Global: Cephalosporin (Oral) Market: Sales Value (in Million US$), 2013-2018
  • Figure 21: Global: Cephalosporin (Oral) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 22: Global: Cephalosporin (Respiratory Tract) Market: Sales Value (in Million US$), 2013-2018
  • Figure 23: Global: Cephalosporin (Respiratory Tract) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 24: Global: Cephalosporin (Skin Infection) Market: Sales Value (in Million US$), 2013-2018
  • Figure 25: Global: Cephalosporin (Skin Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 26: Global: Cephalosporin (Ear Infection) Market: Sales Value (in Million US$), 2013-2018
  • Figure 27: Global: Cephalosporin (Ear Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 28: Global: Cephalosporin (Urinary Tract Infection) Market: Sales Value (in Million US$), 2013-2018
  • Figure 29: Global: Cephalosporin (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 30: Global: Cephalosporin (Sexually Transmitted Infection) Market: Sales Value (in Million US$), 2013-2018
  • Figure 31: Global: Cephalosporin (Sexually Transmitted Infection) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 32: Global: Cephalosporin (Other Applications) Market: Sales Value (in Million US$), 2013-2018
  • Figure 33: Global: Cephalosporin (Other Applications) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 34: Asia Pacific: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
  • Figure 35: Asia Pacific: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 36: Europe: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
  • Figure 37: Europe: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 38: North America: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
  • Figure 39: North America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 40: Middle East and Africa: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
  • Figure 41: Middle East and Africa: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 42: Latin America: Cephalosporin Market: Sales Value (in Million US$), 2013-2018
  • Figure 43: Latin America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Cephalosporin Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Cephalosporin Market Forecast: Breakup by Generation (in Million US$), 2019-2024
  • Table 3: Global: Cephalosporin Market Forecast: Breakup by Route of Administration (in Million US$), 2019-2024
  • Table 4: Global: Cephalosporin Market Forecast: Breakup by Application (in Million US$), 2019-2024
  • Table 5: Global: Cephalosporin Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 6: Global: Cephalosporin Market Structure
  • Table 7: Global: Cephalosporin Market: Key Players
目次
Product Code: SR1019C75_Report

The global cephalosporin market size was worth US$ 11.4 Billion in 2018. Cephalosporins are beta-lactam antibiotics that function in the way similar to penicillin. These broad-spectrum drugs help in treating numerous bacterial infections such as pneumonia, kidney infections, bone infections, meningitis and various sexually transmitted diseases (STDs). There are currently five generations of cephalosporin drugs available in the market with a slight difference in their antibacterial spectrum. These medicines are also differentiated on the basis their administration, excretion, absorption and the duration of the effect of cephalosporin on the body. There are two ways to administer cephalosporin drugs, namely, oral and intravenous (IV). A course of oral cephalosporins is generally used for curing minor infections that are easy to treat such as strep throat. Whereas, IVs are utilized for more severe infections, like meningitis, as these medicines reach tissues quickly than those administered orally.

At present, the rapidly increasing water and air pollution are the primary reasons for the prevalence of infectious diseases across the globe. This has provided a boost to the demand for cephalosporin drugs worldwide. Other than this, various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents. The formation of these partnerships is expected to play a significant role in the growth of the cephalosporin market. Looking forward, IMARC Group expects the market to reach a value of US$ 13.3 Billion by 2024, registering a CAGR of around 3% during 2019-2024.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Generation:

  • First Generation
  • Second Generation
  • Third Generation
  • Fourth Generation
  • Fifth Generation

Market Breakup by Route of Administration:

  • Injection
  • Oral

Market Breakup by Application:

  • Respiratory Tract
  • Skin Infection
  • Ear Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Others

Market Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited (Lupin Pharmaceuticals, Inc., Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Ranbaxy, Merck, etc.

Key Questions Answered in This Report:

  • How has the global cephalosporin market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global cephalosporin industry?
  • What is the breakup of the market based on the generation?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the global cephalosporin industry?
  • What are the key driving factors and challenges in the global cephalosporin industry?
  • What is the structure of the global cephalosporin industry and who are the key players?
  • What is the degree of competition in the global cephalosporin industry?
  • What are the profit margins in the global cephalosporin industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cephalosporin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Breakup by Generation
  • 5.4 Market Breakup by Route of Administration
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Generation

  • 6.1 First Generation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Second Generation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Third Generation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Fourth Generation
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Fifth Generation
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Injection
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Respiratory Tract
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Skin Infection
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ear Infection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Urinary Tract Infection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Sexually Transmitted Infection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 Asia Pacific
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 North America
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

  • 13.1 Price Indicators
  • 13.2 Price Structure
  • 13.3 Margin Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan Plc.
    • 14.3.2 Bristol-Myers Squibb Company
    • 14.3.3 F. Hoffmann-La Roche Ltd.
    • 14.3.4 GlaxoSmithKline plc
    • 14.3.5 Lupin Limited (Lupin Pharmaceuticals, Inc.
    • 14.3.6 Merck & Co. Inc.
    • 14.3.7 Novartis International AG (Sandoz)
    • 14.3.8 Pfizer Inc.
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
    • 14.3.10 Abbott
    • 14.3.11 Ranbaxy
    • 14.3.12 Merck
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.